Beijing Leadman Biochemistry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
April 22, 2022 at 04:18 am EDT
Share
Beijing Leadman Biochemistry Co.,Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 191.58 million compared to CNY 115.72 million a year ago. Revenue was CNY 191.58 million compared to CNY 115.72 million a year ago. Net income was CNY 12.11 million compared to CNY 6.27 million a year ago. Basic earnings per share from continuing operations was CNY 0.022 compared to CNY 0.015 a year ago. Diluted earnings per share from continuing operations was CNY 0.022 compared to CNY 0.015 a year ago.
Beijing Leadman Biochemistry Co., Ltd is a China-based company principally engaged in the research, development, production and sales of in-vitro diagnostic reagents. Its diagnostic reagents include chemiluminescence diagnostic reagents and biochemical diagnostic agents, such as hepatitis B virus attributes and tumor markers. The Company also produces diagnostic instruments and biochemical raw materials. Its diagnostic instruments include automatic luminescence immunity analyzers, among others. Its products are applied in various fields, including liver diseases, kidney diseases, cardiovascular diseases, immunological diseases and diabetes, among others. The Company mainly operates businesses in domestic market.
BEIJING LEADMAN BIOCHEMISTRY CO.,LTD. 
